Profil
Jay C.
Strum has founded Incyclix Bio LLC in 2020, where he currently serves as the Chief Scientific Officer.
He previously worked at GSK Plc as the Director-Genomics Division from 1995 to 2009, and at GlaxoSmithKline LLC as the Manager-Cell Technology Group from 1995 to 2009.
From 2009 to 2020, he served as the Chief Scientific Officer at G1 Therapeutics, Inc. Dr. Strum holds a doctorate degree from Wake Forest University, which he received in 1993, and an undergraduate degree from Western Carolina University, which he received in 1987.
Postes actifs de Jay C. Strum
| Sociétés | Poste | Début |
|---|---|---|
Incyclix Bio LLC
 Incyclix Bio LLC Pharmaceuticals: MajorHealth Technology Incyclix Bio, Inc., formerly known as Arc Therapeutics, is a pharmaceutical company that focuses on developing small molecule inhibitors of cyclin-dependent kinases (CDKs) to treat advanced and resistant cancers. The company is based in Durham, NC. The company's team has unique insights into the biology and structure of CDKs, which will facilitate the rapid discovery and development of a novel, potent, and selective Cdk2 inhibitor. Incyclix Bio was founded by industry experts with robust drug design, discovery, and development experience, including Patrick Roberts, John Bisi, Fredric N. Eshelman, and Jay C. Strum. Patrick Roberts has been the CEO since incorporation. | Founder | 01/05/2020 |
Anciens postes connus de Jay C. Strum
| Sociétés | Poste | Fin |
|---|---|---|
| G1 THERAPEUTICS, INC. | President | - |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | 01/02/2009 |
| GSK PLC | Corporate Officer/Principal | 01/02/2009 |
Formation de Jay C. Strum
| Wake Forest University | Doctorate Degree |
| Western Carolina University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GSK PLC | Health Technology |
| G1 THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
Incyclix Bio LLC
Incyclix Bio LLC Pharmaceuticals: MajorHealth Technology Incyclix Bio, Inc., formerly known as Arc Therapeutics, is a pharmaceutical company that focuses on developing small molecule inhibitors of cyclin-dependent kinases (CDKs) to treat advanced and resistant cancers. The company is based in Durham, NC. The company's team has unique insights into the biology and structure of CDKs, which will facilitate the rapid discovery and development of a novel, potent, and selective Cdk2 inhibitor. Incyclix Bio was founded by industry experts with robust drug design, discovery, and development experience, including Patrick Roberts, John Bisi, Fredric N. Eshelman, and Jay C. Strum. Patrick Roberts has been the CEO since incorporation. | Health Technology |
